Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Journal of Immunology Research|June 1, 2018
Linking Neuroinflammation and Neurodegeneration in Parkinson's DiseaseGéraldine Gelders, Veerle Baekelandt, Anke Van der PerrenCurrent Topics in Behavioral Neurosciences|May 20, 2014
Viral vector-based models of Parkinson's diseaseAnke Van der Perren, Chris Van den Haute, Veerle BaekelandtScientific Reports|August 28, 2019
Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using 18F-FDG PET imagingMartijn Devrome, Cindy Casteels, Anke Van der Perren, et al.Frontiers in Immunology|February 15, 2019
Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein AdministrationJavier María Peralta Ramos, Pablo Iribarren, Luc Bousset, et al.Journal of Neuropathology and Experimental Neurology|January 16, 2014
Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegenerationAnne-Sophie Van Rompuy, Evy Lobbestael, Anke Van der Perren, et al.Journal of Visualized Experiments : Jove|March 12, 2016
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral VectorAnke Van der Perren, Cindy Casteels, Koen Van Laere, et al.Acta Neuropathologica Communications|October 24, 2019
Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's diseaseTeresa Torre-Muruzabal, Jens Devoght, Chris Van den Haute, et al.Neurobiology of Aging|October 23, 2017
Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesiaMelissa Crabbé, Anke Van der Perren, Akila Weerasekera, et al.Experimental Neurology|October 25, 2021
Rab7 reduces α-synuclein toxicity in rats and primary neuronsEva M Szegö, Chris Van den Haute, Lennart Höfs, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2006
Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's diseaseLinda Vercammen, Anke Van der Perren, Elisabetta Vaudano, et al.Pageof 3